Zaltrap 100mg/4ml Injection 1s

Zaltrap 100mg/4ml Injection contains Aflibercept as its active ingredient, an anti-angiogenic agent used within specialised oncology treatment plans, generally administered as part of a combination regimen under close medical supervision. If this has been prescribed for you, it's helpful to know that commonly reported side effects include fatigue, diarrhoea, decreased appetite, or mouth sores, along with changes in blood pressure that your care team will monitor closely. Because this is an infusion-based treatment, it is administered exclusively by trained healthcare professionals in a clinical setting rather than at home. Your oncology team will typically conduct regular blood tests and health checks throughout treatment to monitor your response and safety. Open communication with your care team about any new or worsening symptoms is an essential part of your treatment journey.

Dosage is individually calculated by your oncologist based on body surface area and is generally administered once every two weeks alongside other chemotherapy agents. Your treatment schedule and dose will be determined and adjusted solely by your specialist care team.

• Fatigue
• Diarrhoea
• Decreased appetite
• Mouth sores (stomatitis)
• High blood pressure (hypertension)
• Reduced white blood cell count
• Protein in the urine (proteinuria)
• Headache
• Nosebleeds
• Delayed wound healing

This injection requires refrigerated storage between 2°C and 8°C and must be protected from light, with specific cold-chain handling maintained throughout transport and storage. Storage and handling of this product are managed by licensed pharmacy and healthcare professionals in line with strict clinical protocols.

• Attend all scheduled infusion appointments and follow-up blood tests
• Report any signs of high blood pressure symptoms, such as severe headache, promptly
• Inform your care team of any new bleeding, bruising, or wound healing concerns
• Maintain open communication with your oncology team about all symptoms
• Keep a record of all medications and supplements for your care team
• Follow any dietary or activity guidance provided by your oncologist
• Discuss any planned surgical or dental procedures with your oncology team in advance

Zaltrap is administered as an intravenous infusion by a qualified healthcare professional in a hospital or specialised infusion centre, generally given once every two weeks as part of a combination chemotherapy regimen. This medication is not self-administered at home. Always follow the treatment schedule and preparation instructions set out by your oncology care team.

Zaltrap Injection vials typically have a shelf life of around 24 months from the date of manufacture when stored correctly and unopened. This product is handled and its expiry verified by the pharmacy and clinical team prior to administration.

The active ingredient is Aflibercept 100mg/4ml, an anti-angiogenic agent that works by targeting specific growth factors.

This medication should not be used by individuals with a known hypersensitivity to aflibercept. It requires careful evaluation by an oncologist in individuals with a history of gastrointestinal perforation, significant bleeding, blood clots, or uncontrolled high blood pressure. This treatment is not intended for use during pregnancy or breastfeeding, and your oncology team will discuss suitability based on your full medical history.

Aflibercept may interact with other medications affecting blood clotting or blood pressure, and your oncology team will review all your current medications before and during treatment to manage potential interactions safely. There are no major specific food interactions. Always keep your full medication list updated with your care team throughout treatment.

Can Zaltrap Injection be ordered for Singapore-based patients through your Malaysia pharmacy?
This is a specialised oncology infusion medication administered exclusively in a clinical setting. Please contact our team directly to discuss availability and coordination with your treating hospital or clinic.

Is a prescription required to purchase this medication?
Yes, this is a specialist oncology medication requiring a valid prescription and coordination with your treating oncologist and clinical team.

How is authenticity verified for a specialised medication like this?
This product is sourced directly from verified manufacturers and authorised distributors, with full batch traceability and documentation provided to the dispensing clinical facility.

How does delivery work for a cold-chain injectable medication like this?
Given its temperature-sensitive nature, this product requires specialised cold-chain logistics coordinated directly between our pharmacy and the receiving clinical facility, rather than standard courier delivery.

Is it safe to source specialist oncology medication through a Malaysia-based pharmacy?
Yes, when coordinated properly between licensed pharmacies and your treating medical team, cross-border sourcing of specialist medication follows strict regulatory and clinical safety protocols.

Can this medication be shipped directly to a patient's home in Singapore?
No, this infusion medication must be administered by healthcare professionals in a clinical setting and cannot be self-administered or delivered directly to a residential address.

How can I coordinate an order for this medication with my treating hospital?
Please contact our customer support team directly so we can assist with coordinating your order alongside your treating oncology team's requirements.

What should happen if there are concerns about the product's condition upon receipt by the clinical facility?
Any concerns regarding product condition should be raised immediately between the receiving pharmacy or clinical facility and our supply team for prompt resolution.

Is patient information kept confidential throughout this process?
Yes, we adhere to strict data privacy and confidentiality standards for all patient and prescription information throughout the coordination and supply process.